“Iron Oxide Nanoparticles Functionalized with Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells”, J. Anal. Oncol., vol. 13, pp. 36–42, Dec. 2024, doi: 10.30683/1927-7229.2024.13.06.